Keyword

darolutamide

Description: Darolutamide is a nonsteroidal androgen receptor inhibitor used to treat prostate cancer and studied in oncology and pharmacology.
Wikidata ID: wiki/Q25091391
OpenAlex ID: keywords/darolutamide
2022 · Matthew R. Smith, Maha Hussain, et al. · New England Journal of Medicine · 1,135
2019 · Karim Fizazi, Neal Shore, et al. · New England Journal of Medicine · 997
2020 · Karim Fizazi, Neal Shore, et al. · New England Journal of Medicine · 400
2019 · Meghan A. Rice, Sanjay V. Malhotra, et al. · Frontiers in Oncology · 360
2022 · Yundong He, Weidong Xu, et al. · Signal Transduction and Targeted Therapy · 304
2020 · Umang Swami, Taylor R. McFarland, et al. · Trends in cancer · 281
2022 · Yanhua Chen, Qianqian Zhou, et al. · Cell Death and Disease · 170
2018 · E. David Crawford, Paul F. Schellhammer, et al. · The Journal of Urology · 163
2023 · Ha Yeong Choi, Ji-Eun Chang · International Journal of Molecular Sciences · 158
2021 · Aasems Jacob, Rishi Raj, et al. · Cancers · 158
2021 · Keith T. Schmidt, Alwin D. R. Huitema, et al. · Nature Reviews Urology · 153
2021 · Daniel Westaby, Maria de Los Dolores Fenor de La Maza, et al. · The Annual Review of Pharmacology and Toxicology · 145
2021 · Gaëtan Devos, Wout Devlies, et al. · Nature Reviews Urology · 117
2019 · Charles Ryan, Jeffrey S. Wefel, et al. · Prostate Cancer and Prostatic Diseases · 113
2024 · Maha Hussain, Karim Fizazi, et al. · JAMA Oncology · 109
2019 · Christian Zurth, Mikko Koskinen, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 109
Works count: 1,291
Citation count: 12,790
Year
Topic
Type